Two biotechnology companies are collaborating on using the gene editing technique Crispr to create engineered immune-system cells to treat cancer. . . . → Read More: Biotechs Partner on Gene-Edited Cancer Cell Therapies
|
|||||
|
       
  |
Spark Therapeutics, a developer of gene therapies, is gaining access to a technology that programs DNA sequences like integrated electronic circuits. . . . → Read More: Gene Therapy Company Exploring DNA Circuit Technology  Comments are closed  Intellectual property, Joint ventures/collaborations  biomedical, biotechnology, engineering, entrepreneurs, genomics, licensing, life sciences, pharmaceuticals, university 
A medical device company now offers a synthetic tissue implant for torn rotator cuff, a common sports injury, designed at a Purdue University engineering lab. . . . → Read More: Univ. Lab Develops, Licenses Sports Injury Implant Comments are closed Intellectual property, New products biomedical, biotechnology, engineering, licensing, life sciences, medical device, university 
Drug maker AbbVie is acquiring a technology using the gene-editing process Crispr to produce new off-the-shelf engineered T-cells as disease therapies. . . . → Read More: AbbVie Licenses Engineered Crispr Cell Process Comments are closed Intellectual property, Joint ventures/collaborations biomedical, biotechnology, cancer, equity, genomics, investment, licensing, life sciences, pharmaceuticals, university 
A biotechnology company is adapting and licensing its immunotherapy process, originally designed for cancer, as a cure for HIV infections. . . . → Read More: Cancer Immunotherapy Adapted for HIV Comments are closed Intellectual property, Joint ventures/collaborations biomedical, biotechnology, cancer, equity, genomics, HIV, investment, licensing, life sciences, mathematics, pharmaceuticals, preclinical 
Wellcome Leap aims to establish a model for faster design and development of health breakthroughs, beginning with elimination of administrative obstacles. . . . → Read More: Institutions Join Global Health Breakthrough Network Comments are closed Finance, Intellectual property, Joint ventures/collaborations Africa, Asia, biomedical, DoD, engineering, Europe, grant, life sciences, medical device, U.K., university 
A group of 15 American universities are putting part of their engineering patents into a common licensing pool for commercial development. . . . → Read More: Universities Form Joint Engineering Patent Pool Comments are closed Intellectual property, Joint ventures/collaborations computer science, economics, engineering, licensing, patent, physical sciences, university 
A biotechnology enterprise is licensing research from Stanford University on messenger RNA to produce proteins that rejuvenate cells damaged by aging. . . . → Read More: Biotech Licenses mRNA Technology for Aging One comment - (Comments are closed) Intellectual property biomedical, biotechnology, entrepreneurs, genomics, licensing, life sciences, pharmaceuticals, preclinical, stem cells, university 
Global drug maker Boehringer Ingelheim is gaining access to an immunotherapy technology that targets usually hidden proteins to attack cancer cells. . . . → Read More: Drug Maker Gains Access to Hidden Protein Immunotherapies Comments are closed Intellectual property biomedical, biotechnology, cancer, Europe, genomics, licensing, life sciences, pharmaceuticals, U.K., university 
Drug maker AbbVie is licensing a synthetic antibody to treat Covid-19 and SARS coronaviruses that the company began funding in June. . . . → Read More: AbbVie Acquires Coronavirus Antibody Therapy One comment - (Comments are closed) Intellectual property, New products biomedical, biotechnology, China, clinical trials, Covid-19, Europe, genomics, licensing, life sciences, pharmaceuticals, preclinical, university |
||||
|
Copyright © 2021 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||